We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 11, 2020

CLN5 in Heterozygosis May Protect Against the Development of Tumors in a VHL Patient

Orphanet Journal of Rare Diseases

 

Additional Info

Disclosure statements are available on the authors' profiles:

Orphanet Journal of Rare Diseases
CLN5 in Heterozygosis May Protect Against the Development of Tumors in a VHL Patient
Orphanet J Rare Dis 2020 Jun 02;[EPub Ahead of Print], I de Rojas-P, V Albiñana, L Recio-Poveda, A Rodriguez-Rufián, ÁM Cuesta, LM Botella

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading